Filing Flows

Filing Flows › Glaukos (GKOS) › Next earnings date

Glaukos (GKOS) earnings

Glaukos (GKOS) last reported on Oct 28, 2026: revenue $211M for the third quarter 2026. The next date is not set yet. It beat the EPS estimate in 80% of the quarters on record.

Beat rate80%

The last report

Glaukos reported revenue of $211M for the third quarter 2026 (+58% Y/Y), net earnings $2.0M: Glaucoma $152M, Corneal Health $59.0M. How it makes money → · Every quarter →

Glaukos: EPS against the estimate, last 5 reportsGlaukos: EPS against the estimate, last 5 reportsEstimateReported−$0.26−$0.16Oct 25−$0.20−$0.28Feb 26−$0.28−$0.18Apr 26−$0.21−$0.14Jul 26−$0.09$0.47Oct 26
Latest (Oct 26): Estimate −$0.09, Reported $0.47.
GKOS: the stock's move on each reportGKOS: the stock's move on each reportJul 29, 2026+11.4%Apr 29, 2026+20.1%Feb 17, 2026+10.5%Oct 29, 2025+12.9%

Glaukos' latest quarter

Glaukos, Q3 2026: revenue $211M (+58% year over year), operating margin 0.4%, net earnings $2.0M, operating cash flow $38.6M. The chart follows the revenue to costs, profit and cash.

Questions

When does GKOS report earnings?

The next date is not set yet.

Does Glaukos usually beat earnings?

It beat the consensus EPS estimate in 80% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.